Bioequivalence Study to Assess Systemic Exposure of FP and SAL FDC From Different DPIs
Clinical trial NCT02215122 · COMPLETED
Trial details
- NCT number
- NCT02215122
- Sponsor
- Mylan Pharma UK Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-01
- Primary completion
- 2013-11-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.